In recent years, immunophenotype and cytochemistry analysis are found valuable in the diagnosis of AML, and immunophenotyping surface type molecules like CD123, CD45, CD34, CD38 have been reported to help confirm the diagnosis of AML (Prada-Arismendy, Arroyave & Röthlisberger, 2017). Here, CD38 is linked to acute myeloid leukemia.